Table 4.
AE/biotech drug association reported more than once during the study period by Clinical Units.
| Onco-hematology | Rheumatology | Hepato-gastroenterology | Dermatology | Neurology | |
|---|---|---|---|---|---|
| Abatacept | – | Insomnia | |||
| Adalimumab | – | Infusion reactions, URTI, insomnia | Generalized pain, myalgia, Infusion reactions | Skin eruption | |
| Bevacizumab | Paresthesia, neutropenia, asthenia | ||||
| Brentuximab | Paresthesia, neuropathy, diarrhea, headache, cough | ||||
| Certolizumab pegol | – | Flu-like syndrome | – | – | – |
| Cetuximab | Rash, diarrhea, skin fissures | ||||
| Eculizumab | Myalgia, constipation | ||||
| Etanercept | – | Myalgia, peripheral edema | Hypertension | ||
| Golimumab | – | URTI | – | – | – |
| Infliximab | – | Generalized edema, bone or joint pain | Headache, dizziness, tachycardia | – | – |
| Natalizumab | – | – | – | – | Headache |
| Panitumumab | Rash, skin toxicity | – | |||
| Rituximab | Paresthesia, nausea, asthenia | Purpura | – | – | – |
| Tocilizumab | – | Itch, abdominal pain, dyspnea, leukopenia, rash | – | – | – |
| Trastuzumab | Asthenia, neutropenia, diarrhea | – | – | – | – |
URTI, upper respiratory tract infection.